BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11485818)

  • 1. MDM2: life without p53.
    Daujat S; Neel H; Piette J
    Trends Genet; 2001 Aug; 17(8):459-64. PubMed ID: 11485818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and activation of p53 and its family members.
    Lohrum MA; Vousden KH
    Cell Death Differ; 1999 Dec; 6(12):1162-8. PubMed ID: 10637431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
    Gu J; Nie L; Kawai H; Yuan ZM
    Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.
    Martin K; Trouche D; Hagemeier C; Sørensen TS; La Thangue NB; Kouzarides T
    Nature; 1995 Jun; 375(6533):691-4. PubMed ID: 7791903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of MDM2 protein in the cell cycle].
    Szemraj J; Rozpończyk E; Bartkowiak J; Greger J; Oszajca K
    Postepy Biochem; 2005; 51(1):44-51. PubMed ID: 16209341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 and MDMX bind and stabilize the p53-related protein p73.
    Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.
    Klein AM; Biderman L; Tong D; Alaghebandan B; Plumber SA; Mueller HS; van Vlimmeren A; Katz C; Prives C
    Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34716260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
    Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
    J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible role of p73 on the modulation of p53 level through MDM2.
    Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
    Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human ARF binds E2F1 and inhibits its transcriptional activity.
    Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
    Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying p53 family proteins in yeast: induction of autophagic cell death and modulation by interactors and small molecules.
    Leão M; Gomes S; Bessa C; Soares J; Raimundo L; Monti P; Fronza G; Pereira C; Saraiva L
    Exp Cell Res; 2015 Jan; 330(1):164-77. PubMed ID: 25265062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
    Xiao ZX; Chen J; Levine AJ; Modjtahedi N; Xing J; Sellers WR; Livingston DM
    Nature; 1995 Jun; 375(6533):694-8. PubMed ID: 7791904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
    Gu J; Nie L; Wiederschain D; Yuan ZM
    Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p14(ARF) regulates E2F activity.
    Mason SL; Loughran O; La Thangue NB
    Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MdmX represses E2F1 transactivation.
    Wunderlich M; Ghosh M; Weghorst K; Berberich SJ
    Cell Cycle; 2004 Apr; 3(4):472-8. PubMed ID: 14739777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.
    Gu J; Chen D; Rosenblum J; Rubin RM; Yuan ZM
    Mol Cell Biol; 2000 Feb; 20(4):1243-53. PubMed ID: 10648610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of p53 and its homolog p73 by protoporphyrin IX.
    Sznarkowska A; Maleńczyk K; Kadziński L; Bielawski KP; Banecki B; Zawacka-Pankau J
    FEBS Lett; 2011 Jan; 585(1):255-60. PubMed ID: 21146529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
    Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
    J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.